EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."
Orthopedic Implants Maker Zimmer Biomet Gains Analyst Upgrade Amid Promising Growth From New Products, Demographic Trends
Zimmer Biomet receives an upgrade from Argus Research due to new product launches and strategic acquisitions.
What’s Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
FDA staff reviewers raise concerns over Guardant Health's experimental Shield blood test for colorectal cancer, citing low sensitivity in detecting certain tumor types. Shield aims to improve early CRC detection and compliance, potentially extending patient survival.
Weight Loss Drugs Like Wegvoy and Zepbound Users – Nestlé Launches $5 Pizza For You
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide.
Oil Giant Dives Deep in Angola: TotalEnergies Greenlights Kaminho FPSO Unit
TotalEnergies SE and partners disclosed FID for the Kaminho project in Angola. The project plans to develop fields and reduce methane emissions.
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Valisure sues GSK accusing the company of hiding cancer risks linked to Zantac, potentially defrauding the U.S. government. This follows Valisure's 2019 tests showing Zantac forms a carcinogen, prompting a whistleblower lawsuit seeking billions in damages.
Stocks Hold Steady On Mixed Fed Remarks, First Solar Rallies, Bitcoin Falls Below $70,000: What’s Driving Markets Tuesday?
It’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York.
UnitedHealth’s OptumRx Unveils New Transparent Drug Pricing Initiative for 2024
UnitedHealth's OptumRx will implement a new pricing model, OptumRx Clear Trend Guarantee, starting next year.
KKR Injects Cash And Expertise Into Healthcare Tech Company Infinx
KKR to acquire minority stake in Infinx, leveraging its expertise in healthcare and technology to drive growth and expand network.
Nickel Crisis Fuels Unrest In New Caledonia, Pushes Prices Above $20,000 Per Ton
Concerns over supply disruptions from New Caledonia, combined with sanctions on Russian metal, have pushed prices above $20,000 per ton.